MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 186 filers reported holding MANNKIND CORP in Q2 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,689,453 | +2.0% | 323,650 | -11.5% | 0.00% | 0.0% |
Q1 2024 | $1,656,748 | +22.9% | 365,728 | -1.2% | 0.00% | 0.0% |
Q4 2023 | $1,347,572 | -2.8% | 370,212 | +10.2% | 0.00% | 0.0% |
Q3 2023 | $1,386,961 | +20.9% | 335,826 | +19.2% | 0.00% | 0.0% |
Q2 2023 | $1,146,845 | -57.3% | 281,780 | -57.0% | 0.00% | -50.0% |
Q1 2023 | $2,685,340 | -17.7% | 654,961 | +5.8% | 0.00% | -33.3% |
Q4 2022 | $3,263,537 | +208.2% | 619,267 | +80.7% | 0.00% | +200.0% |
Q3 2022 | $1,059,000 | -19.5% | 342,679 | -0.7% | 0.00% | 0.0% |
Q2 2022 | $1,315,000 | +2.7% | 345,114 | -0.9% | 0.00% | 0.0% |
Q1 2022 | $1,281,000 | -13.4% | 348,080 | +2.8% | 0.00% | 0.0% |
Q4 2021 | $1,479,000 | -2.1% | 338,486 | -2.5% | 0.00% | 0.0% |
Q3 2021 | $1,510,000 | -19.7% | 347,200 | +0.6% | 0.00% | -50.0% |
Q2 2021 | $1,880,000 | +40.6% | 344,973 | +1.2% | 0.00% | +100.0% |
Q1 2021 | $1,337,000 | +46.3% | 341,008 | +16.8% | 0.00% | 0.0% |
Q4 2020 | $914,000 | +64.4% | 291,931 | -1.2% | 0.00% | 0.0% |
Q3 2020 | $556,000 | -9.7% | 295,541 | -16.1% | 0.00% | 0.0% |
Q2 2020 | $616,000 | +73.5% | 352,125 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $355,000 | -31.6% | 344,767 | -14.2% | 0.00% | 0.0% |
Q4 2019 | $519,000 | +8.1% | 402,016 | +4.7% | 0.00% | 0.0% |
Q3 2019 | $480,000 | +13.7% | 383,818 | +4.5% | 0.00% | 0.0% |
Q2 2019 | $422,000 | -41.4% | 367,156 | +0.5% | 0.00% | 0.0% |
Q1 2019 | $720,000 | +101.7% | 365,262 | +8.5% | 0.00% | 0.0% |
Q4 2018 | $357,000 | -24.7% | 336,699 | +30.1% | 0.00% | 0.0% |
Q3 2018 | $474,000 | +15.6% | 258,824 | +19.8% | 0.00% | 0.0% |
Q2 2018 | $410,000 | +24.6% | 216,030 | +49.6% | 0.00% | 0.0% |
Q1 2018 | $329,000 | -9.4% | 144,359 | -7.8% | 0.00% | 0.0% |
Q4 2017 | $363,000 | +65.0% | 156,554 | +54.6% | 0.00% | – |
Q3 2017 | $220,000 | +78.9% | 101,288 | +16.2% | 0.00% | – |
Q2 2017 | $123,000 | +46.4% | 87,182 | +54.3% | 0.00% | – |
Q1 2017 | $84,000 | – | 56,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
180 WEALTH ADVISORS, LLC | 1,485,335 | $4,590,000 | 1.26% |
1492 Capital Management LLC | 546,710 | $1,689,000 | 1.22% |
Parkman Healthcare Partners LLC | 924,979 | $2,858,000 | 0.81% |
EMERALD ADVISERS, LLC | 3,765,284 | $11,635,000 | 0.60% |
Avoro Capital Advisors LLC | 9,100,000 | $28,119,000 | 0.52% |
Telemetry Investments, L.L.C. | 90,000 | $278,000 | 0.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,775,609 | $5,487,000 | 0.35% |
SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,147,000 | 0.20% |
Bruce & Co., Inc. | 195,073 | $602,000 | 0.16% |
DUPONT CAPITAL MANAGEMENT CORP | 726,200 | $2,244,000 | 0.13% |